Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Loss, Lags Revenue Estimates

Apellis Pharmaceuticals, Inc. (APLS) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of$ 0.66. This compares to loss of $1.50 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -10.61%. A quarter ago, it was expected that this company would post a loss of$ 0.84 per share when it actually produced a loss of $1.17, delivering a surprise of -39.29%.Over the last four quarters, the comp ...